Biden’s State of the Union Address Offers Consumers More Falsehoods
Today, Gerard Scimeca, Chairman of Consumer Action for a Strong Economy, issued the following statement in response to President...
Today, Gerard Scimeca, Chairman of Consumer Action for a Strong Economy, issued the following statement in response to President...
October 4, 2023 President Biden announced yesterday that the makers of the first 10 drugs selected for so-called Medicare...
September 13, 2023 (Alexandria, Virginia) — Today Consumer Action for a Strong Economy (CASE), urged the House Committee on...
September 1, 2023 The rise of pharmacy benefit managers (PBMs) has transformed them into the dominant force in U.S....
May 19, 2023 The Strengthening Medicare and Reducing Taxpayer (SMART) Prices Act introduced by U.S. Senators Amy Klobuchar (D-MN),...
February 3, 2023 It’s not your grandparents’ AARP anymore. Whether it’s their celebration of the Inflation Reduction Act or historical support of Obamacare,...
January 25, 2023 Make no mistake, Congress and the Biden administration took a sledgehammer to the American healthcare system...
November 7, 2022 The 340B program, a flawed plan that allows hospitals to steal savings meant for low-income patients,...
August 18, 2022 Gerard Scimeca Chairman, CASE As President Biden and Democrats celebrate their reconciliation “victory,” American patients are...
August 9, 2022 Today, Gerard Scimeca, Chairman of Consumer Action for a Strong Economy, issued the following statement denouncing...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2024 · Case for Consumers